Associated Press/Johnson & Johnson (file)

FDA report: Single-dose vaccine safe and effective

by Rachel Lynn Aldrich
Posted 2/24/21, 04:49 pm

Johnson & Johnson’s COVID-19 shot is about 66 percent effective against moderate to severe illness and 85 percent effective at preventing severe cases. U.S. Food and Drug Administration scientists on Wednesday also said the single-dose vaccine is safe, paving the way for the agency’s advisers to meet on Friday to debate whether to grant emergency use authorization.

Read more

Associated Press/Photo by Francis Kokoroko/UNICEF

Global vaccine effort still behind schedule

International | The multilateral COVAX program lags as India clamps down on exports
by Mindy Belz
Posted 2/24/21, 04:24 pm

GHANA received the first shipment of coronavirus vaccines under the multilateral program COVAX today—600,000 vials for the country of 30 million that this month has seen a record spike in COVID-19 cases. But the international effort to assist poorer countries remains behind schedule as distribution of vaccines under the European-led effort lags.

Read more

Associated Press/Photo by Danny Lawson (file)

U.K. ethics panel approves risky COVID-19 study

by Kent Covington
Posted 2/17/21, 04:22 pm

Researchers in London will intentionally infect people with the novel coronavirus for the first time. The United Kingdom’s Research Ethics Committee approved the first COVID-19 human challenge study on Wednesday. Scientists are looking for young, healthy volunteers between 18 and 30 to expose to very small amounts of the original coronavirus strain for a study of transmission and immune system response. Doctors will monitor participants 24 hours a day.

Read more